by Jason Heaviland | Apr 21, 2026
PRMT5 Metabolomics Panel for Patient Stratification This poster presents a targeted, multiplexed LC-MS/MS metabolomics assay developed to support patient stratification and pharmacodynamic monitoring for MTA-cooperative PRMT5 inhibitors in oncology research....
by Jason Heaviland | Apr 10, 2026 | Uncategorized
Terms like “comprehensive coverage” and “untargeted detection” are widely used in metabolomics, but they are rarely evaluated in controlled comparisons. Panome Bio conducted a head-to-head study against a widely used legacy platform using identical samples,...
by ODWAdmin | Apr 6, 2026 | Uncategorized
For decades, Formalin-Fixed Paraffin-Embedded (FFPE) tissue has been the standard for preserving clinical samples. From cancer biopsies to organ tissue, this method is used across hospitals and research centers worldwide to store biological material for long-term use...
by Jason Heaviland | Mar 31, 2026
Metabolomics Comparison: A Head-to-Head Study Panome Bio conducted a controlled head-to-head metabolomics study using identical samples analyzed by a legacy library-based platform and Next-Generation Metabolomics®️. The results show a nearly 4× increase in detected...
by Jason Heaviland | Mar 31, 2026 | Uncategorized
Researchers run experiments, send samples, and receive results that appear complete. However, a significant portion of the metabolome may never be captured in the final dataset. Not due to sample quality or preparation, but because many metabolomics platforms are...
